Prophylactic and therapeutic use of antibodies for protection against respiratory infection with Francisella tularensis

Journal of Immunology

Volumn 179, Issue 1, 2007, Pages 532-539

  Kirimanjeswara, Girish S ^a   Golden, Jacqueline M ^a   Bakshi, Chandra Shekhar ^a   Metzger, Dennis W ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTISERUM; CLODRONIC ACID; FC RECEPTOR; GAMMA INTERFERON; IMMUNOGLOBULIN; LIVE VACCINE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL KILLING; CELLULAR IMMUNITY; CLEARANCE; CONTROLLED STUDY; FRANCISELLA TULARENSIS; GENE EXPRESSION; HUMORAL IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; LETHALITY; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NEUTROPHIL; NONHUMAN; OPSONIZATION; PASSIVE IMMUNIZATION; PHAGOCYTE; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SCID MOUSE; T LYMPHOCYTE; TULAREMIA;

EID: 34250834960     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.179.1.532     Document Type: Article

References (32)

1. Ellis, J., P. C. Oyston, M. Green, and R. W. Titball. 2002. Tularemia. Clin. Microbiol. Rev. 15: 631-634.
2. Oyston, P. C., A. Sjostedt, and R. W. Titball. 2004. Tularemia: bioterrorism defence renews interest in Francisella tularensis. Nat. Rev. Microbiol. 2: 967-978.
3. Gallagher-Smith, M., J. Kim, R. Al-Bawardy, and D. Josko. 2004. Francisella tularensis: possible agent in bioterrorism. Clin. Lab. Sci. 17: 35-39.
4. Elkins, K. L., T. R. Rhinehart-Jones, S. J. Culkin, D. Yee, and R. K. Winegar. 1996. Minimal requirements for murine resistance to infection with Francisella tularensis LVS. Infect. Immun. 64: 3288-3293.
5. Elkins, K. L., R. K. Winegar, C. A. Nacy, and A. H. Fortier. 1992. Introduction of Francisella tularensis at skin sites induces resistance to infection and generation of protective immunity. Microb. Pathog. 13: 417-421.
6. Sjostedt, A., R. I. North, and J. W. Conlan. 1996. The requirement of tumor necrosis factor-α and interferon-γ for the expression of protective immunity to secondary murine tularemia depends on the size of the challenge inoculum. Microbiology 142: 1369-1374.
7. + T cells does not affect the magnitude of protective immunity to an intracellular pathogen: Francisella tularensis strain LVS. J. Immunol. 157: 5042-5048.
8. Culkin, S. J., T. Rhinehart-Jones, and K. L. Elkins. 1997. A novel role for B cells in early protective immunity to an intracellular pathogen: Francisella tularensis strain LVS. J. Immunol. 158: 3277-3284.
9. Elkins, K. L., C. M. Bosio, and T. R. Rhinehart-Jones. 1999. Importance of B cells, but not specific antibodies, in primary and secondary protective immunity to the intracellular bacterium Francisella tularensis live vaccine strain. Infect. Immun. 67: 6002-6007.
10. Drabick, J. J., R. B. Narayanan, J. C. Williams, J. W. Leduc, and C. A. Nacy. 1994. Passive protection of mice against lethal Francisella tularensis (live tularemia vaccine strain) infection by the sera of human recipients of the live tularemia vaccine. Am. J. Med. Sci. 308: 83-87.
11. Fulop, M., P. Mastroeni, M. Green, and R. W. Titball. 2001. Role of antibody to lipopolysaccharide in protection against low- and high-virulence strains of Francisella tularensis. Vaccine 19: 4465-4472.
12. Rhinehart-Jones, T. R., A. H. Fortier, and K. L. Elkins. 1994. Transfer of immunity against lethal murine Francisella infection by specific antibody depends on host γ interferon and T cells. Infect. Immun. 62: 3129-3137.
13. Stenmark, S., H. Lindgren, A. Tarnvik, and A. Sjostedt. 2003. Specific antibodies contribute to the host protection against strains of Francisella tularensis subspecies holarctica. Microb. Pathog. 35: 73-80.
14. Chen, W., H. Shen, A. Webb, R. KuoLee, and J. W. Conlan. 2003. Tularemia in BALB/c and C57BL/6 mice vaccinated with Francisella tularensis LVS and challenged intradermally, or by aerosol with virulent isolates of the pathogen: protection varies depending on pathogen virulence, route of exposure, and host genetic background. Vaccine 21: 3690-3700.
15. Shen, H., W. Chen, and J. W. Conlan. 2004. Susceptibility of various mouse strains to systemically- or aerosol-initiated tularemia by virulent type A Francisella tularensis before and after immunization with the attenuated live vaccine strain of the pathogen. Vaccine 22: 2116-2121.
16. Conlan, W. J., H. Shen, R. Kuolee, X. Zhao, and W. Chen. 2005. Aerosol-, but not intradermal-, immunization with the live vaccine strain of Francisella tularensis protects mice against subsequent aerosol challenge with a highly virulent type A strain of the pathogen by an αβ T cell- and interferon γ-dependent mechanism. Vaccine 23: 2477-2485.
17. Wu, T. H., J. A. Hutt, K. A. Garrison, L. S. Berliba, Y. Zhou, and C. R. Lyons. 2005. Intranasal vaccination induces protective immunity against intranasal infection with virulent Francisella tularensis biovar A. Infect. Immun. 73: 2644-2654.
18. Circolo, A., G. Gamier, W. Fukuda, X. Wang, T. Hidvegi, A. J. Szalai, D. E. Briles, J. E. Volanakis, R. A. Wetsel, and H. R. Colten. 1999. Genetic disruption of the murine complement C3 promoter region generates deficient mice with extrahepatic expression of C3 mRNA. Immunopharmacology 42: 135-149.
19. Baron, S. D., R. Singh, and D.W. Metzger. 2007. Inactivated Francisella tularensis LVS protects against respiratory tularemia by intranasal vaccination in an IgA-dependent fashion. Infect. Immun. 75: 2152-2162.
20. Malik, M., C. S. Bakshi, B. Sahay, A. Shah, S. A. Lotz, and T. J. Sellati. 2006. Toll-like receptor 2 is required for control of pulmonary infection with Francisella tularensis. Infect. Immun. 74: 2152-2162.
21. Cote, C. K., N. Van Rooijen, and S. L. Welkos. 2006. Roles of macrophages and neutrophils in the early host response to Bacillus anthracis spores in a mouse model of infection. Infect. Immun. 74: 469-480.
22. Malik, M., C. S. Bakshi, K. McCabe, S. V. Heron, A. Shah, R. Singh, P. L. Jackson, A. Gaggar, D. W. Metzger, J. A. Melendez, et al. 2007. Matrix metalloproteinase 9 (MMP-9) activity enhances host susceptibility to pulmonary Infection with type A and B strains of Francisella tularensis. J. Immunol. 178: 1013-1020.
23. Sjostedt, A., J. W. Conlan, and R. J. North. 1994. Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect. Immun. 62: 2779-2783.
24. Lindgren, H., L. Stenman, A. Tarnvik, and A. Sjostedt. 2005. The contribution of reactive nitrogen and oxygen species to the killing of Francisella tularensis LVS by murine macrophages. Microbes Infect. 7: 467-475.
25. Lopez, M. C., N. S. Duckett, S. D. Baron, and D. W. Metzger. 2004. Early activation of NK cells after lung infection with the intracellular bacterium: Francisella tularensis LVS. Cell. Immunol. 232: 75-85.
26. Casadevall, A., and L. A. Pirofski. 2006. A reappraisal of humoral immunity based on mechanisms of antibody-mediated protection against intracellular pathogens. Adv. Immunol. 91: 1-44.
27. Foshay, L. 1946. A comparative study of the treatment of tularemia with immune serum, hyperimmune serum and streptomycin. Am. J. Med. 1: 180-188.
28. Polsinelli, T., M. S. Meltzer, and A. H. Fortier. 1994. Nitric oxide-independent killing of Francisella tularensis by IFN-γ-stimulated murine alveolar macrophages. J. Immunol. 153: 1238-1245.
29. Green, S. J., C. A. Nacy, R. D. Schreiber, D. L. Granger, R. M. Crawford, M. S. Meltzer, and A. H. Fortier. 1993. Neutralization of γ interferon and tumor necrosis factor α blocks in vivo synthesis of nitrogen oxides from L-arginine and protection against Francisella tularensis infection in Mycobacterium bovis BCG-treated mice. Infect. Immun. 61: 689-698.
30. Bosio, C. M., and K. L. Elkins. 2001. Susceptibility to secondary Francisella tularensis live vaccine strain infection in B-cell-deficient mice is associated with neutrophilia but not with defects in specific T-cell-mediated immunity. Infect. Immun. 69: 194-203.
31. Pammit, M. A., E. K. Raulie, C. M. Lauriano, K. E. Klose, and B. P. Arulanandam. 2006. Intranasal vaccination with a defined attenuated Francisella novicida strain induces γ interferon-dependent antibody-mediated protection against tularemia. Infect. Immun. 74: 2063-2071.
32. Bosio, C. M., H. Bielefeldt-Ohmann, and J. T. Belisle. 2007. Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J. Immunol. 178: 4538-4547.